The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Educational Lecture

Educational Lecture 2-1B Role of novel proteasome inhibitors in the treatment of relapsed/refractory multiple myeloma

Sun. Oct 14, 2018 1:10 PM - 1:40 PM No.6 (Osaka International Convention Center, 10F 1003)

Chair: Hirokazu Murakami (Gunma University Graduate School of Health Sciences, Japan)

[EL2-1B] Role of novel proteasome inhibitors in the treatment of relapsed/refractory multiple myeloma

Masaki Ri (Department of Hematology & Oncology, Nagoya City University Graduate School of Medical Sciences, Japan)